Noel Arce
Family Medicine · Gilbert, AZNPI 1831290873
Payments from drug & device makers
Across 77 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$175
- Boston Scientific$130
- Urogen Pharma, Inc.$128
- Astellas Pharma US Inc$110
- Johnson & Johnson$106
- Sumitomo Pharma America, Inc.$96
- plus $844 from 20 others
What the payments were for
- Food & beverage$1,589100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 8 | $175 |
| Boston Scientific | 7 | $130 |
| Urogen Pharma, Inc. | 7 | $128 |
| Astellas Pharma US Inc | 4 | $110 |
| Johnson & Johnson | 6 | $106 |
| Sumitomo Pharma America, Inc. | 4 | $96 |
| Endo USA, Inc. | 4 | $76 |
| Procept Biorobotics Corporation | 1 | $67 |
| Coloplast | 3 | $65 |
| Novartis | 2 | $60 |
| Bayer | 3 | $57 |
| AstraZeneca | 3 | $52 |
| Laborie Medical Technologies Corp. | 3 | $52 |
| Blue Earth Diagnostics | 2 | $48 |
| 180 Medical, Inc. | 2 | $47 |
| Axonics, Inc. | 2 | $46 |
| Antares Pharma, Inc. | 2 | $44 |
| Myriad Genetic Laboratories, Inc. | 3 | $43 |
| AbbVie | 2 | $36 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
| Progenics Pharmaceuticals, Inc. | 2 | $34 |
| Innovation Technologies Inc | 1 | $21 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $17 |
| Agiliti Surgical, Inc. | 1 | $16 |
| Tolmar, Inc. | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
How this compares
$1,589 in reported general payments places this provider in the 75th percentile of 2,099 family medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 32 | $27,213 |
| Tamsulosin Hcl | 1,005 | $18,021 |
| Finasteride | 783 | $11,742 |
| Potassium Citrate ErPotassium Citrate | 26 | $2,483 |
| Estradiol | 17 | $2,360 |
| Cefdinir | 166 | $2,097 |
| Oxybutynin Chloride | 94 | $2,086 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 64 | $1,751 |
| Solifenacin Succinate | 47 | $1,702 |
| Fosfomycin Tromethamine | 13 | $1,402 |
| Cephalexin | 193 | $955 |
| Dutasteride | 28 | $789 |
| Trospium Chloride | 12 | $539 |
| Ciprofloxacin Hcl | 78 | $460 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $430 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $110 | $27,21332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Gilbert
- Sunildat MaheshwariGilbert$2M
- Lawrence FeldGilbert$382K
- Danielle ArmasScottsdale$73M
- Terry O'ReillyMesa$35.8M
- Shawn SearleChandler$27M
- Corey AndersonMesa$21.5M
- Dena PetersenTucson$14.7M
- Gerald ShockeyMesa$12.3M
- Brock MerrittPhoenix$8.4M
- John McGettiganTucson$8.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.